Knowledge Distillery

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2…

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled…

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

In this open-label, adaptive, multiplatform, randomized clinical trial, critically ill COVID-19 patients were randomly assigned to a regimen of either…

In this article the authors hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized…

In this study the authors trialled daily testing of contacts as an alternative to assess whether this resulted in similar control of transmission,…

In this study the authors aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with standard of care alone in patients…

In this study the authors conducted an open-label, randomized controlled trial of convalescent plasma for adults with COVID-19 receiving oxygen within…

In this ongoing trial, the authors randomly assigned 44,165 participants aged 16 or older and 2,264 participants aged 12-15 to receive two 30-μg…